Hippo Signaling Pathway Dysregulation in Human Huntington’s Disease Brain and Neuronal Stem Cells
Abstract The Hippo signaling pathway is involved in organ size regulation and tumor suppression. Although inhibition of Hippo leads to tumorigenesis, activation of Hippo may play a role in neurodegeneration. Specifically, activation of the upstream regulator, mammalian sterile 20 (STE20)-like kinase...
Guardado en:
Autores principales: | , , , , , , , , , , , , , |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2018
|
Materias: | |
Acceso en línea: | https://doaj.org/article/cccd0dab16664adfba16dc950c90aec9 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
id |
oai:doaj.org-article:cccd0dab16664adfba16dc950c90aec9 |
---|---|
record_format |
dspace |
spelling |
oai:doaj.org-article:cccd0dab16664adfba16dc950c90aec92021-12-02T15:09:07ZHippo Signaling Pathway Dysregulation in Human Huntington’s Disease Brain and Neuronal Stem Cells10.1038/s41598-018-29319-42045-2322https://doaj.org/article/cccd0dab16664adfba16dc950c90aec92018-07-01T00:00:00Zhttps://doi.org/10.1038/s41598-018-29319-4https://doaj.org/toc/2045-2322Abstract The Hippo signaling pathway is involved in organ size regulation and tumor suppression. Although inhibition of Hippo leads to tumorigenesis, activation of Hippo may play a role in neurodegeneration. Specifically, activation of the upstream regulator, mammalian sterile 20 (STE20)-like kinase 1 (MST1), reduces activity of the transcriptional co-activator Yes-Associated Protein (YAP), thereby mediating oxidative stress-induced neuronal death. Here, we investigated the possible role of this pathway in Huntington’s disease (HD) pathogenesis. Our results demonstrate a significant increase in phosphorylated MST1, the active form, in post-mortem HD cortex and in the brains of CAG knock-in Hdh Q111/Q111 mice. YAP nuclear localization was also decreased in HD post-mortem cortex and in neuronal stem cells derived from HD patients. Moreover, there was a significant increase in phosphorylated YAP, the inactive form, in HD post-mortem cortex and in Hdh Q111/Q111 brain. In addition, YAP was found to interact with huntingtin (Htt) and the chaperone 14-3-3, however this interaction was not altered in the presence of mutant Htt. Lastly, YAP/TEAD interactions and expression of Hippo pathway genes were altered in HD. Together, these results demonstrate that activation of MST1 together with a decrease in nuclear YAP could significantly contribute to transcriptional dysregulation in HD.Kaly A. MuellerKelly E. GlajchMegan N. HuizengaRemi A. WilsonEric J. GranucciAmanda M. DiosAdelaide R. TousleyMaria IulianoElizabeth WeismanMichael J. LaQuagliaMarian DiFigliaKimberly Kegel-GleasonKhashayar VakiliGhazaleh Sadri-VakiliNature PortfolioarticleMedicineRScienceQENScientific Reports, Vol 8, Iss 1, Pp 1-13 (2018) |
institution |
DOAJ |
collection |
DOAJ |
language |
EN |
topic |
Medicine R Science Q |
spellingShingle |
Medicine R Science Q Kaly A. Mueller Kelly E. Glajch Megan N. Huizenga Remi A. Wilson Eric J. Granucci Amanda M. Dios Adelaide R. Tousley Maria Iuliano Elizabeth Weisman Michael J. LaQuaglia Marian DiFiglia Kimberly Kegel-Gleason Khashayar Vakili Ghazaleh Sadri-Vakili Hippo Signaling Pathway Dysregulation in Human Huntington’s Disease Brain and Neuronal Stem Cells |
description |
Abstract The Hippo signaling pathway is involved in organ size regulation and tumor suppression. Although inhibition of Hippo leads to tumorigenesis, activation of Hippo may play a role in neurodegeneration. Specifically, activation of the upstream regulator, mammalian sterile 20 (STE20)-like kinase 1 (MST1), reduces activity of the transcriptional co-activator Yes-Associated Protein (YAP), thereby mediating oxidative stress-induced neuronal death. Here, we investigated the possible role of this pathway in Huntington’s disease (HD) pathogenesis. Our results demonstrate a significant increase in phosphorylated MST1, the active form, in post-mortem HD cortex and in the brains of CAG knock-in Hdh Q111/Q111 mice. YAP nuclear localization was also decreased in HD post-mortem cortex and in neuronal stem cells derived from HD patients. Moreover, there was a significant increase in phosphorylated YAP, the inactive form, in HD post-mortem cortex and in Hdh Q111/Q111 brain. In addition, YAP was found to interact with huntingtin (Htt) and the chaperone 14-3-3, however this interaction was not altered in the presence of mutant Htt. Lastly, YAP/TEAD interactions and expression of Hippo pathway genes were altered in HD. Together, these results demonstrate that activation of MST1 together with a decrease in nuclear YAP could significantly contribute to transcriptional dysregulation in HD. |
format |
article |
author |
Kaly A. Mueller Kelly E. Glajch Megan N. Huizenga Remi A. Wilson Eric J. Granucci Amanda M. Dios Adelaide R. Tousley Maria Iuliano Elizabeth Weisman Michael J. LaQuaglia Marian DiFiglia Kimberly Kegel-Gleason Khashayar Vakili Ghazaleh Sadri-Vakili |
author_facet |
Kaly A. Mueller Kelly E. Glajch Megan N. Huizenga Remi A. Wilson Eric J. Granucci Amanda M. Dios Adelaide R. Tousley Maria Iuliano Elizabeth Weisman Michael J. LaQuaglia Marian DiFiglia Kimberly Kegel-Gleason Khashayar Vakili Ghazaleh Sadri-Vakili |
author_sort |
Kaly A. Mueller |
title |
Hippo Signaling Pathway Dysregulation in Human Huntington’s Disease Brain and Neuronal Stem Cells |
title_short |
Hippo Signaling Pathway Dysregulation in Human Huntington’s Disease Brain and Neuronal Stem Cells |
title_full |
Hippo Signaling Pathway Dysregulation in Human Huntington’s Disease Brain and Neuronal Stem Cells |
title_fullStr |
Hippo Signaling Pathway Dysregulation in Human Huntington’s Disease Brain and Neuronal Stem Cells |
title_full_unstemmed |
Hippo Signaling Pathway Dysregulation in Human Huntington’s Disease Brain and Neuronal Stem Cells |
title_sort |
hippo signaling pathway dysregulation in human huntington’s disease brain and neuronal stem cells |
publisher |
Nature Portfolio |
publishDate |
2018 |
url |
https://doaj.org/article/cccd0dab16664adfba16dc950c90aec9 |
work_keys_str_mv |
AT kalyamueller hipposignalingpathwaydysregulationinhumanhuntingtonsdiseasebrainandneuronalstemcells AT kellyeglajch hipposignalingpathwaydysregulationinhumanhuntingtonsdiseasebrainandneuronalstemcells AT megannhuizenga hipposignalingpathwaydysregulationinhumanhuntingtonsdiseasebrainandneuronalstemcells AT remiawilson hipposignalingpathwaydysregulationinhumanhuntingtonsdiseasebrainandneuronalstemcells AT ericjgranucci hipposignalingpathwaydysregulationinhumanhuntingtonsdiseasebrainandneuronalstemcells AT amandamdios hipposignalingpathwaydysregulationinhumanhuntingtonsdiseasebrainandneuronalstemcells AT adelaidertousley hipposignalingpathwaydysregulationinhumanhuntingtonsdiseasebrainandneuronalstemcells AT mariaiuliano hipposignalingpathwaydysregulationinhumanhuntingtonsdiseasebrainandneuronalstemcells AT elizabethweisman hipposignalingpathwaydysregulationinhumanhuntingtonsdiseasebrainandneuronalstemcells AT michaeljlaquaglia hipposignalingpathwaydysregulationinhumanhuntingtonsdiseasebrainandneuronalstemcells AT mariandifiglia hipposignalingpathwaydysregulationinhumanhuntingtonsdiseasebrainandneuronalstemcells AT kimberlykegelgleason hipposignalingpathwaydysregulationinhumanhuntingtonsdiseasebrainandneuronalstemcells AT khashayarvakili hipposignalingpathwaydysregulationinhumanhuntingtonsdiseasebrainandneuronalstemcells AT ghazalehsadrivakili hipposignalingpathwaydysregulationinhumanhuntingtonsdiseasebrainandneuronalstemcells |
_version_ |
1718387904181436416 |